ZA921230B - Improved activation of recombinant proteins - Google Patents
Improved activation of recombinant proteinsInfo
- Publication number
- ZA921230B ZA921230B ZA921230A ZA921230A ZA921230B ZA 921230 B ZA921230 B ZA 921230B ZA 921230 A ZA921230 A ZA 921230A ZA 921230 A ZA921230 A ZA 921230A ZA 921230 B ZA921230 B ZA 921230B
- Authority
- ZA
- South Africa
- Prior art keywords
- recombinant proteins
- amino acids
- improved activation
- helper sequences
- relative hydrophobicities
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Adhesive Tapes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4105480A DE4105480A1 (de) | 1991-02-21 | 1991-02-21 | Verbesserte aktivierung von rekombinanten proteinen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA921230B true ZA921230B (en) | 1992-11-25 |
Family
ID=6425597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA921230A ZA921230B (en) | 1991-02-21 | 1992-02-20 | Improved activation of recombinant proteins |
Country Status (20)
Country | Link |
---|---|
US (1) | US5578710A (fr) |
EP (1) | EP0500108B1 (fr) |
JP (1) | JP2528232B2 (fr) |
KR (1) | KR950014493B1 (fr) |
AT (1) | ATE144284T1 (fr) |
AU (1) | AU641081B2 (fr) |
CA (1) | CA2061569C (fr) |
CZ (1) | CZ282744B6 (fr) |
DE (2) | DE4105480A1 (fr) |
DK (1) | DK0500108T3 (fr) |
ES (1) | ES2093122T3 (fr) |
FI (1) | FI106029B (fr) |
GR (1) | GR3021395T3 (fr) |
HU (1) | HU214881B (fr) |
IE (1) | IE920276A1 (fr) |
IL (1) | IL101024A (fr) |
MX (1) | MX9200709A (fr) |
NO (1) | NO300329B1 (fr) |
NZ (1) | NZ241570A (fr) |
ZA (1) | ZA921230B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022431A1 (fr) * | 1993-03-30 | 1994-10-13 | Pharmacia Ab | Preparation a liberation controlee contenant un sel de morphine |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
MXPA03002046A (es) | 2000-09-08 | 2003-07-24 | Massachusetts Inst Technology | Composiciones analogos de factor estimulador de colonias de granulocitos y metodos para su elaboracion. |
KR100899970B1 (ko) | 2001-02-19 | 2009-05-28 | 메르크 파텐트 게엠베하 | T-세포 에피토프의 동정 방법 및 감소된 면역원성을 갖는분자의 제조를 위한 용도 |
AU2002325819B2 (en) | 2001-07-11 | 2008-06-19 | Maxygen, Inc. | G-CSF Conjugates |
AU2003210052A1 (en) | 2002-03-20 | 2003-09-29 | Biopolymed Inc. | Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
US7666627B2 (en) * | 2002-08-08 | 2010-02-23 | Targetex Kft. | Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
CA2586365A1 (fr) | 2004-11-05 | 2006-05-26 | Northwestern University | Utilisation de scf et de scf dans le traitement de l'ischemie cerebrale et des troubles neurologiques |
CA2607844C (fr) | 2005-06-01 | 2012-07-10 | Maxygen Holdings Ltd. | Polypeptides g-csf pegyles et procedes de production correspondants |
EP2049524A2 (fr) * | 2006-07-24 | 2009-04-22 | Tetralogic Pharmaceuticals Corporation | Inhibiteurs des iap |
EP2185689A2 (fr) | 2007-08-09 | 2010-05-19 | Genzyme Corporation | Procédé de traitement d'une maladie auto-immune avec des cellules souches mésenchymateuses |
US8758761B2 (en) | 2007-09-30 | 2014-06-24 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
WO2011109556A2 (fr) | 2010-03-04 | 2011-09-09 | Pfenex Inc. | Procédé pour la production de la protéine interféron recombinante soluble sans dénaturation |
NZ601759A (en) * | 2010-03-17 | 2013-07-26 | Biogenerix Gmbh | Method for obtaining biologically active recombinant human g-csf |
WO2011123570A2 (fr) | 2010-04-01 | 2011-10-06 | Pfenex Inc. | Procédés pour la production de g-csf dans une cellule hôte de pseudomonas |
EP2880169B1 (fr) * | 2012-08-02 | 2017-05-17 | F. Hoffmann-La Roche AG | Procédé de production de molécules monomères et multimères et leurs utilisations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
DK55685A (da) * | 1985-02-07 | 1986-08-08 | Nordisk Gentofte | Enzym eller enzymkompleks med proteolytisk aktivitet |
US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US5082775A (en) * | 1984-05-11 | 1992-01-21 | Berlex Laboratories, Inc. | Efficient process for isolating insoluble heterologous protein using non-ionic detergents |
US4948729A (en) * | 1985-03-25 | 1990-08-14 | Cetus Corporation | Production of soluble recombinant proteins |
US4783415A (en) * | 1985-03-28 | 1988-11-08 | Meiji Seika Kabushiki Kaisha | Gene coding for signal peptides and utilization thereof |
US5087564A (en) * | 1985-06-20 | 1992-02-11 | Monsanto Company | Release of recombinant peptides from polypeptides using V8 endopeptidase |
DE3636903A1 (de) * | 1985-12-21 | 1987-07-02 | Hoechst Ag | Fusionsproteine mit eukaryotischem ballastanteil |
JPH0618781B2 (ja) * | 1986-10-18 | 1994-03-16 | 中外製薬株式会社 | 感染症治療剤 |
US5013653A (en) * | 1987-03-20 | 1991-05-07 | Creative Biomolecules, Inc. | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
AU605291B2 (en) * | 1987-03-20 | 1991-01-10 | Micromet Ag | Process for the purification of recombinant polypeptides |
WO1988010299A1 (fr) * | 1987-06-24 | 1988-12-29 | Novo-Nordisk A/S | Procede de preparation d'une proteine ou d'un polypeptide, sequence d'adn codant pour le polypeptide, microorganisme contenant la sequence d'adn et le polypeptide et utilisation du polypeptide comme preparation pharmaceutique |
DE3835350A1 (de) * | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
ZA901719B (en) * | 1989-03-19 | 1991-01-30 | Akzo Nv | Hog cholera virus vaccine and diagnostics |
US5191063A (en) * | 1989-05-02 | 1993-03-02 | University Of Medicine And Dentistry Of New Jersey | Production of biologically active polypeptides by treatment with an exogenous peptide sequence |
US5115102A (en) * | 1989-07-21 | 1992-05-19 | Monsanto Company | Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
JPH06500084A (ja) * | 1990-08-20 | 1994-01-06 | ノボ ノルディスク アクティーゼルスカブ | 生物学的に活性な化合物、その製造方法及びその利用 |
-
1991
- 1991-02-21 DE DE4105480A patent/DE4105480A1/de not_active Withdrawn
-
1992
- 1992-01-28 IE IE027692A patent/IE920276A1/en not_active IP Right Cessation
- 1992-02-10 NZ NZ241570A patent/NZ241570A/en not_active IP Right Cessation
- 1992-02-14 AU AU10948/92A patent/AU641081B2/en not_active Ceased
- 1992-02-20 AT AT92102864T patent/ATE144284T1/de not_active IP Right Cessation
- 1992-02-20 ZA ZA921230A patent/ZA921230B/xx unknown
- 1992-02-20 ES ES92102864T patent/ES2093122T3/es not_active Expired - Lifetime
- 1992-02-20 DE DE59207351T patent/DE59207351D1/de not_active Revoked
- 1992-02-20 DK DK92102864.3T patent/DK0500108T3/da active
- 1992-02-20 CA CA002061569A patent/CA2061569C/fr not_active Expired - Fee Related
- 1992-02-20 EP EP92102864A patent/EP0500108B1/fr not_active Revoked
- 1992-02-20 HU HU9200548A patent/HU214881B/hu not_active IP Right Cessation
- 1992-02-20 FI FI920742A patent/FI106029B/fi not_active IP Right Cessation
- 1992-02-20 MX MX9200709A patent/MX9200709A/es not_active IP Right Cessation
- 1992-02-20 CZ CS92499A patent/CZ282744B6/cs not_active IP Right Cessation
- 1992-02-20 IL IL10102492A patent/IL101024A/en not_active IP Right Cessation
- 1992-02-20 JP JP4033257A patent/JP2528232B2/ja not_active Expired - Lifetime
- 1992-02-20 NO NO920671A patent/NO300329B1/no unknown
- 1992-02-21 KR KR1019920002697A patent/KR950014493B1/ko not_active IP Right Cessation
-
1993
- 1993-10-21 US US08/139,054 patent/US5578710A/en not_active Expired - Lifetime
-
1996
- 1996-10-17 GR GR960402469T patent/GR3021395T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022431A1 (fr) * | 1993-03-30 | 1994-10-13 | Pharmacia Ab | Preparation a liberation controlee contenant un sel de morphine |
Also Published As
Publication number | Publication date |
---|---|
IE920276A1 (en) | 1992-08-26 |
CA2061569A1 (fr) | 1992-08-22 |
NO920671L (no) | 1992-08-24 |
ES2093122T3 (es) | 1996-12-16 |
DK0500108T3 (da) | 1997-03-24 |
EP0500108A3 (en) | 1993-04-07 |
HU214881B (hu) | 1998-07-28 |
CS49992A3 (en) | 1992-09-16 |
EP0500108A2 (fr) | 1992-08-26 |
NO920671D0 (no) | 1992-02-20 |
HUT68021A (en) | 1995-04-04 |
US5578710A (en) | 1996-11-26 |
HU9200548D0 (en) | 1992-04-28 |
AU641081B2 (en) | 1993-09-09 |
JPH05244977A (ja) | 1993-09-24 |
IL101024A0 (en) | 1992-11-15 |
JP2528232B2 (ja) | 1996-08-28 |
FI920742A0 (fi) | 1992-02-20 |
EP0500108B1 (fr) | 1996-10-16 |
AU1094892A (en) | 1992-08-27 |
KR920016464A (ko) | 1992-09-24 |
GR3021395T3 (en) | 1997-01-31 |
NZ241570A (en) | 1994-09-27 |
ATE144284T1 (de) | 1996-11-15 |
NO300329B1 (no) | 1997-05-12 |
KR950014493B1 (ko) | 1995-12-02 |
DE59207351D1 (de) | 1996-11-21 |
FI920742A (fi) | 1992-08-22 |
CZ282744B6 (cs) | 1997-09-17 |
CA2061569C (fr) | 2000-10-24 |
IL101024A (en) | 1996-06-18 |
FI106029B (fi) | 2000-11-15 |
DE4105480A1 (de) | 1992-08-27 |
MX9200709A (es) | 1992-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0500108A3 (en) | Improved activation of recombinant proteins | |
DE69033040T2 (de) | Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF) | |
DE69529219D1 (en) | Helicobacter proteine und impstoffe | |
AU669483B2 (en) | Nucleotide sequences and resistance proteins cycloheximide | |
ES2124247T3 (es) | Conjugado de calcitonina y de polietilenglicol. | |
DE68907635D1 (de) | Loetmaterial fuer brillengestelle und brillengestelle, bei denen dieses loetmaterial verwendet ist. | |
DK0652903T3 (da) | Nyt humant rekombinant gammainterferon | |
SE9602822D0 (sv) | New receptor | |
AU3902489A (en) | Non-glycosylated, recombinant human IL2 in the reduced form, the process for obtaining it and its use as a medicament | |
DK1431391T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
ES2078229T3 (es) | Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion. | |
IT8719551A0 (it) | Plasmidi ricombinanti utili perl'espressione in bacillus di proteine eterologhe. | |
EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
GB9604518D0 (en) | Novel compounds | |
DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
ATE76081T1 (de) | Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren. |